Gadobutrol is a second-generation, non-ionic macrocyclic gadolinium-based contrast agent (GBCA) used in magnetic resonance imaging (MRI). It is formulated at a higher gadolinium concentration than other GBCAs, requiring a smaller injection volume, and the macrocyclic structure is associated with a lower risk of nephrogenic systemic fibrosis (NSF).
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 138071-82-6
Calcobutrol
chelating agent for diagnostic imaging
Gadobutrol
MRI contrast agent
2,2'-(4,10-bis(1,3,4-Trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid
chelating agent intermediate
2,2'-(4,10-Bis(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid tetrahydrochloride
Gadobutrol impurity reference standard
Agomélatine
active pharmaceutical ingredient
Levofloxacin hydrate
active pharmaceutical ingredient
Tropifexor
active pharmaceutical ingredient
Irbésartan
active pharmaceutical ingredient
2-[4,10-bis(carboxylatomethyl)-7-[(2R,3S)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
ZPDFIIGFYAHNSK-CTHHTMFSSA-K
C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])[C@H](CO)[C@@H](CO)O)CC(=O)[O-].[Gd+3]